Table 3.
Number of patients achieving the targets recommended by the ATTD consensus for glucose metrics using FSL1 then switching to DG4.
| Metrics | Target Values 1 | FSL1 M0 2 | DG4 M6 2 | DG4 M12 2 |
|---|---|---|---|---|
| % CV, n | ≤36% | 2 | 7 | 6 |
| TBR < 54 mg/dL, n | <1% | 6 | 7 | 13 |
| TBR < 70 mg/dL, n | <4% | 4 | 7 | 14 |
| TIR 70–180 mg/dL, n | >70% | 1 | 5 | 3 |
| TAR > 180 mg/dL, n | <25% | 3 | 6 | 3 |
| TAR > 250 mg/dL, n | <5% | 2 | 7 | 4 |
| GMI, n | <7% | 6 | 8 | 4 |
1 Target values recommended by the ATTD 2019 [23]. 2 Data represent the n number out of 21 studied T1D patients reaching the targeted value for a given metric using FSL1 (M0) or after the switch to DG4 used over 6 (M6) or 12 (M12) months. Abbreviations: ATTD, Advanced Technologies & treatments for Diabetes); CGM, continuous glucose monitoring; %CV, glucose % coefficient of variation; DG4, Dexcom G4 platinum; FSL1, FreeStyle Libre version 1; GMI, glucose management indicator; T1D, type 1 diabetes; TAR, time-above-range; TBR, time-below-range; TIR, time-in-range.